These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 15876995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB, Warfarin Optimal Duration Italian Trial (WODIT) Investigators.
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [Abstract] [Full Text] [Related]

  • 3. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.
    Circulation; 2004 Aug 03; 110(5):566-70. PubMed ID: 15262837
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antiphospholipid syndrome and venous thromboembolism: the role of congenital thrombophilia].
    Poli D, Gensini GF.
    Ann Ital Med Int; 2005 Aug 03; 20(4):218-23. PubMed ID: 16610253
    [Abstract] [Full Text] [Related]

  • 7. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
    Hendler MF, Meschengieser SS, Blanco AN, Alberto MF, Salviú MJ, Gennari L, Lazzari MA.
    Am J Hematol; 2004 Aug 03; 76(4):330-7. PubMed ID: 15282664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombophilia and risk of venous thrombosis in patients with cancer.
    Decousus H, Moulin N, Quenet S, Bost V, Rivron-Guillot K, Laporte S, Mismetti P.
    Thromb Res; 2007 Aug 03; 120 Suppl 2():S51-61. PubMed ID: 18023713
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.